v3.26.1
SCHEDULE OF WARRANT ACTIVITY (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Subsidiary or Equity Method Investee [Line Items]      
Outstanding Aggregate Intrinsic Value $ 2,501,040  
Outstanding shares 1,735,869    
Outstanding Aggregate Intrinsic Value $ 6,744,540 $ 2,501,040
Warrants Vested and expected to vest, Aggregate Intrinsic Value 1,415    
Warrants Exercisable, Aggregate Intrinsic Value $ 1,415    
Viral Clear Pharmaceuticals Inc [Member]      
Subsidiary or Equity Method Investee [Line Items]      
Outstanding shares 473,772    
Weighted average remaining contractual term, outstanding 1 year 10 months 24 days 2 years 10 months 24 days 3 years 10 months 24 days
Warrants exercisable, shares 473,772    
Weighted average exercise price, exercisable $ 5.00    
Weighted average remaining contractual term, exercisable 1 year 10 months 24 days    
Outstanding shares, beginning 480,347 480,347  
Weighted average exercise price, beginning $ 5.07 $ 5.07  
Forfeited/expired 6,575  
Forfeited/expired (6,575)  
Weighted average exercise price,forfeited/expired $ 10.00    
Outstanding shares, ending 473,772 480,347 480,347
Weighted average exercise price, ending $ 5.00 $ 5.07 $ 5.07
BioSig AI Sciences, Inc. [Member]      
Subsidiary or Equity Method Investee [Line Items]      
Outstanding shares 4,899,716 2,748,371  
Weighted-Average Exercise Price, beginning $ 4.88 $ 7.40  
Weighted-Average Remaining Contractual Term, Ending Outstanding   3 years 6 months 3 years 8 months 12 days
Outstanding Aggregate Intrinsic Value $ 405 $ 1,717  
Issued 758,514 2,202,697  
Weighted-Average Exercise Price Issued $ 0.95 $ 2.00  
Weighted-Average Remaining Contractual Term, Issued 3 years 5 years  
Exercised (2,357,377) (51,352)  
Weighted-Average Exercise Price Exercised $ 2.41 $ 0.30  
Exercised (886,206)    
Weighted-Average Exercise Price Expired $ 41.32    
Repurchased for cash (Fundamental Transaction election) (678,778)    
Weighted-Average Exercise Price Repurchased for cash $ 2.07    
Outstanding shares 1,735,869 4,899,716 2,748,371
Weighted-Average Exercise Price ending $ 6.94    
Weighted average remaining contractual term, outstanding   2 years 9 months 18 days  
Outstanding Aggregate Intrinsic Value $ 1,415 $ 405 $ 1,717
Warrants Vested and expected to vest, Shares 1,735,869    
Weighted-Average Exercise Price Vested and expected to vest $ 6.94    
Weighted-Average Remaining Contractual Term Vested and expected to ves 2 years 9 months 18 days    
Warrants exercisable, shares 1,735,869    
Weighted average exercise price, exercisable $ 6.94    
Weighted average remaining contractual term, exercisable 2 years 9 months 18 days